Measles outbreaks in the Kyeongin area of the Republic of Korea, 2013 –2014: A single-center experience in a country of measles elimination

Conclusions Early weaning of maternally derived measles antibodies therefore vaccination of MCV1 at a young age from 9 months to 12 months should be considered in situations of early exposure. Furthermore, there is a call for consideration of scheduling an earlier age for the first dose of MMR vaccine in Europe. It is necessary for Korea to investigate the duration of the presence and quantitative analysis of maternal measles antibodies in infants and to reconsider the timing of MCV1.
Source: Asian Pacific Journal of Tropical Medicine - Category: Tropical Medicine Source Type: research